Chesapeake Energy Corp (CHK) 6.80 $CHK SmarTrend

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chesapeake Energy Corp (CHK) 6.80 $CHK

SmarTrend Watching for Potential Pullback in Shares of Chesapeake Energy After 3.48% Gain
Comtex SmarTrend(R) - Tue Sep 06, 2:28PM CDT
Chesapeake Energy (NYSE:CHK) traded in a range yesterday that spanned from a low of $6.66 to a high of $6.86. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $6.70 on volume of 20.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CHK: 6.80 (+0.20)

After Yesterday's Rally of 3.48% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Sep 06, 2:26PM CDT
Chesapeake Energy (NYSE:CHK) traded in a range yesterday that spanned from a low of $6.66 to a high of $6.86. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $6.70 on volume of 20.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CHK: 6.80 (+0.20)

Chesapeake Energy (CHK) Approaches New Upside Target of $6.93
Comtex SmarTrend(R) - Tue Sep 06, 9:05AM CDT
Chesapeake Energy (NYSE:CHK) has opened bullishly above the pivot of $6.53 today and has reached the first level of resistance at $6.77. Should the shares continue to rise, the resistance pivots of $6.93 and $7.33 will be of interest.
CHK: 6.80 (+0.20)

Chesapeake Energy Has Returned 32.4% Since SmarTrend Recommendation (CHK)
Comtex SmarTrend(R) - Tue Sep 06, 1:27AM CDT
SmarTrend identified an Uptrend for Chesapeake Energy (NYSE:CHK) on June 8th, 2016 at $4.99. In approximately 3 months, Chesapeake Energy has returned 32.40% as of today's recent price of $6.60.
CHK: 6.80 (+0.20)

Chesapeake Energy Set to Possibly Pullback After Yesterday's Rally of 1.32%
Comtex SmarTrend(R) - Tue Aug 30, 1:09PM CDT
Chesapeake Energy (NYSE:CHK) traded in a range yesterday that spanned from a low of $6.47 to a high of $6.65. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $6.54 on volume of 17.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CHK: 6.80 (+0.20)

Look for Shares of Chesapeake Energy to Potentially Pullback after Yesterday's 1.32% Rise
Comtex SmarTrend(R) - Tue Aug 30, 1:08PM CDT
Chesapeake Energy (NYSE:CHK) traded in a range yesterday that spanned from a low of $6.47 to a high of $6.65. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $6.54 on volume of 17.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CHK: 6.80 (+0.20)

Watch for Shares of Chesapeake Energy (CHK) to Approach Resistance at $6.63
Comtex SmarTrend(R) - Tue Aug 30, 9:19AM CDT
Chesapeake Energy (NYSE:CHK) has opened bullishly above the pivot of $6.39 today and has reached the first level of resistance at $6.54. Investors may be interested in a cross of the next upside pivot targets of $6.63 and $6.87.
CHK: 6.80 (+0.20)

Uptrend Call Working As Chesapeake Energy Stock Rises 28.6% (CHK)
Comtex SmarTrend(R) - Mon Aug 29, 1:24PM CDT
SmarTrend identified an Uptrend for Chesapeake Energy (NYSE:CHK) on June 8th, 2016 at $4.99. In approximately 3 months, Chesapeake Energy has returned 28.59% as of today's recent price of $6.41.
CHK: 6.80 (+0.20)

Williams Appoints Three New Independent Directors
BusinessWire - Mon Aug 29, 7:00AM CDT
--New, Independent Directors Bring Significant Public Company Leadership Experience and Deep Energy Industry Knowledge
CHK: 6.80 (+0.20), WMB: 29.16 (+0.76), WPZ: 40.02 (+1.55)

Chesapeake Energy (CHK) Breaks Through Resistance at $6.45
Comtex SmarTrend(R) - Fri Aug 26, 9:22AM CDT
Shares of Chesapeake Energy (NYSE:CHK) opened today above their pivot of $6.32 and have already reached the first level of resistance at $6.45. Investors may be interested in a cross of the next upside pivot targets of $6.56 and $6.80.
CHK: 6.80 (+0.20)

Chesapeake Energy Corporation Announces Early Results Of Cash Tender Offers For Non-Convertible Senior Notes
PR Newswire - Fri Aug 26, 6:00AM CDT
Chesapeake Energy Corporation (NYSE:CHK) reported today the results to date of its pending cash tender offers (the "Tender Offers" for the outstanding notes of Chesapeake set forth in the table below (collectively, the "Notes".
CHK: 6.80 (+0.20)

Chesapeake Energy Corporation Announces Increase In Size Of Cash Tender Offers For Contingent Convertible Senior Notes
PR Newswire - Fri Aug 26, 6:00AM CDT
Chesapeake Energy Corporation (NYSE:CHK) announced today that, with respect to its offers to purchase for cash (the "Tender Offers" the outstanding notes of Chesapeake set forth in the table below (collectively, the "Notes", it has increased the aggregate purchase price offered for the Notes in the Tender Offers, exclusive of accrued interest, from up to $500,000,000 aggregate purchase price to up to $750,000,000 (the "New Aggregate Maximum Purchase Amount" and, in connection therewith, established a tender cap of $600,000,000 aggregate purchase price (exclusive of accrued interest) for the 2.5% Contingent Convertible Senior Notes due 2037 (the "2037 Notes". No change was made to the tender cap for the 2.25% Contingent Convertible Notes due 2038 (the "2038 Notes" and, except as provided for in this release, all other terms and conditions of the Tender Offers remain unchanged as set forth in an Offer to Purchase dated August 15, 2016 (as amended, the "Offer to Purchase" and the related Letter of Transmittal.
CHK: 6.80 (+0.20)

Duke University files $9.9 million claim on McClendon estate
By TIM TALLEY - AP - Thu Aug 25, 2:09PM CDT
OKLAHOMA CITY (AP) — Duke University has filed a $9.9 million claim against the estate of former Chesapeake Energy Corp. CEO Aubrey McClendon for pledges the Duke alumnus made that the university says were unpaid at the time of his death in a fiery highway crash.
CHK: 6.80 (+0.20)

Williams Confirms Receipt of Corvex Director Nominations
BusinessWire - Wed Aug 24, 10:09AM CDT
The Williams Companies, Inc. (NYSE:WMB) ("Williams" or the "Company" today confirmed that Corvex Management LP ("Corvex" has nominated ten Corvex employees, including Keith Meister, to stand for election to the Company's Board of Directors (the "Board" at the 2016 Annual Meeting of Stockholders to be held on Wednesday, November 23, 2016.
CHK: 6.80 (+0.20), WMB: 29.16 (+0.76)

After Yesterday's Rally of 6.57% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Aug 23, 12:14PM CDT
Chesapeake Energy (NYSE:CHK) traded in a range yesterday that spanned from a low of $6.03 to a high of $6.58. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $6.25 on volume of 37.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CHK: 6.80 (+0.20)

Oil & Gas Stock Roundup: Exxon, Chevron & Hess to Bid Jointly for Mexico Drilling Rights
Nilanjan Choudhury - Zacks Investment Research - Tue Aug 23, 10:03AM CDT
On the news front, oil giants Exxon Mobil Corp. (XOM), Chevron Corp. (CVX) and Hess Corp. (HES) have joined forces to bid for deepwater drilling rights in Mexico.
VLO: 55.27 (+0.44), CLR: 50.41 (+0.12), HES: 51.23 (-1.85), BBG: 6.63 (-0.11), CHK: 6.80 (+0.20), XOM: 88.57 (+1.15), CVX: 102.43 (+1.50)

Williams Comments on the Corvex Plan to Nominate Directors
BusinessWire - Mon Aug 22, 1:03PM CDT
The Williams Companies, Inc. (NYSE: WMB) ("Williams" or the "Company", in response to comments from Keith Meister of Corvex Management LP ("Corvex" that Corvex intends to nominate 10 of its employees to stand for election to the Company's Board of Directors at the 2016 Annual Meeting of Stockholders, issued the following statement:
CHK: 6.80 (+0.20), WMB: 29.16 (+0.76)

Chesapeake Energy Up 22.5% Since SmarTrend Uptrend Call (CHK)
Comtex SmarTrend(R) - Fri Aug 19, 1:41PM CDT
SmarTrend identified an Uptrend for Chesapeake Energy (NYSE:CHK) on June 8th, 2016 at $4.99. In approximately 2 months, Chesapeake Energy has returned 22.47% as of today's recent price of $6.11.
CHK: 6.80 (+0.20)

Chesapeake (CHK) Reveals Pricing & Upsizing of Term Loan
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 4:26PM CDT
Oklahoma-based Chesapeake Corporation (CHK) declared the pricing and the upsizing of a secured five-year term loan as a result of strong demand.
DVN: 44.21 (-0.06), CHK: 6.80 (+0.20), PE: 34.77 (-0.09), MUSA: 74.45 (+0.50)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 180

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 410

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 298

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 317

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 343

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 229

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading